INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial halted early: testing a scarring drug for rare lung disease
Disease control TerminatedThis study aimed to see if adding the drug nintedanib to standard immune-suppressing medications was safe and tolerable for adults with myositis-related interstitial lung disease (MA-ILD), a condition where muscle inflammation causes progressive lung scarring. The goal was to slo…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Drug trial aims to help kids breathe easier
Disease control TerminatedThis study tested whether the drug hydroxychloroquine could help children with rare, chronic lung scarring diseases breathe better. It involved 35 young patients and had two parts: one to see if starting the drug helped, and another to see if stopping it made symptoms worse. The …
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Matthias Griese • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC